e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Treatment of lung cancer and lung metastases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low tri-iodothyronine state: a relevant factor in determining outcome in thoracic surgery patients? Evidence from a clinical study
E. Scoscia, L. Di Carlo, A. Semeraro, S. Baglioni, T. Todisco, G. Daddi, M. Ragusa (Perugia, Italy)
Source:
Annual Congress 2004 - Treatment of lung cancer and lung metastases
Session:
Treatment of lung cancer and lung metastases
Session type:
Poster Discussion
Number:
384
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Scoscia, L. Di Carlo, A. Semeraro, S. Baglioni, T. Todisco, G. Daddi, M. Ragusa (Perugia, Italy). Low tri-iodothyronine state: a relevant factor in determining outcome in thoracic surgery patients? Evidence from a clinical study. Eur Respir J 2004; 24: Suppl. 48, 384
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Low tri-iodothyronine state is a prognostic marker of short term outcome in thoracic surgery patients
Source: Eur Respir J 2005; 26: Suppl. 49, 68s
Year: 2005
Post thoracic surgery low tri-iodothyronine state: a potential index of outcome?
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008
Low-t3 state a crucial biomarker in determining NIV failure and outcome in pulmonary patient?
Source: Annual Congress 2011 - Mechanical ventilation and weaning
Year: 2011
Physical function performance and recovery of patients undergoing abdominal surgery in relation to post-operative complications–A prospective real world study.
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018
Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Applicability of pulmonary rehabilitation in primary care: critical success factors, use of patient reported outcomes and consequences of population differences
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011
Predictive factors: can we identify patients who will benefit from a specific treatment?
Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer
Year: 2011
Physical activity level in patients with bronchiectasis: a systematic review of determinants and outcome measures
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
Prognostic indices for COPD patient management: how many do we need?
Source: Eur Respir J 2011; 39: 223-224
Year: 2012
COPD management: finding patient related factor of non-adherence
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009
Prognostic indices for COPD patient management: how many do we need?
Source: Eur Respir J 2012; 39: 223-224
Year: 2012
Predictive modelling for optimization of preoperative care in multimorbid patients undergoing major surgery
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020
Late Breaking Abstract - A single centre observational study of inflammatory biomarkers in Covid 19 and clinically important outcomes
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Pulmonary rehabilitation: can we identify the patients who will benefit most?
Source: Eur Respir J 2001; 18: Suppl. 33, 187s
Year: 2001
Circulating cell free RNA level and clinical response to the chemotherapy in patients with thoracic malignancy
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Sarcoidosis treatment and outcomes: what is most important to patients?
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003
A prospective study of factors predicting postoperative pulmonary complications (PPC) in patients undergoing non-cardiothoracic surgery under general anaesthesis (GA)
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept